Guidelines Working Group Members
acknowledgements
ESMO Clinical Recommendations
Primary breast cancer
Locally recurrent or metastatic breast cancer
BRCA in breast cancer
Newly and relapsed epithelial ovarian carcinoma
Non-epithelial ovarian cancer
Cervical cancer
Endometrial carcinoma
Esophageal cancer
Gastric cancer
Pancreatic cancer
Hepatocellular carcinoma
Biliary cancer
Primary colon cancer
Familial colorectal cancer risk
Rectal cancer
Anal cancer
Advanced colorectal cancer
Gastrointestinal stromal tumours
Non-small-cell lung cancer
Small-cell lung cancer
Malignant pleural mesothelioma
Prostate cancer
Invasive bladder cancer
Renal cell carcinoma
Testicular seminoma
Testicular non-seminoma
Multiple myeloma
Acute myeloblastic leukemia in adult patients
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Hodgkin's lymphoma
Diffuse large B-cell non-Hodgkin's lymphoma
Gastric marginal zone lymphoma of MALT type
Primary cutaneous lymphoma
Newly diagnosed and relapsed follicular lymphoma
Squamous cell carcinoma of the head and neck
Nasopharyngeal cancer
Malignant glioma
Cutaneous malignant melanoma
Soft tissue sarcomas
Osteosarcoma
Ewing's sarcoma of the bone
Differentiated thyroid cancer
Neuroendocrine bronchial and thymic tumors
Neuroendocrine gastroenteropancreatic tumors
Cancers of unknown primary site
Chemotherapy-induced nausea and vomiting
Erythropoiesis-stimulating agents in cancer patients
Hematopoietic growth factors
Management of febrile neutropenia
Management of cancer pain
Management of oral and gastrointestinal mucositis
Cancer, fertility and pregnancy
Management of venous thromboembolism in cancer patients
ESMO Guidelines Working Group Disclosures